Eta-secretase-like processing of the amyloid precursor protein (APP) by RHBDL4

The amyloid precursor protein (APP) has been extensively studied with regards to its contribution to the pathology of Alzheimers disease. APP is an ubiquitously expressed type I transmembrane protein synthesized in the endoplasmic reticulum (ER) and translocated to the plasma membrane where it undergoes proteolytic cleavages by several identified proteases. Conversely to other known proteases, we previously elucidated human rhomboid protease RHBDL4 as a novel APP processing enzyme where several cleavages likely occur already in the ER. Interestingly, the pattern of RHBDL4-derived large APP C-terminal fragments resemble those generated by the {eta}-secretase or MT5-MMP, which was described to generate so called A{eta} fragments. The similarity in large APP C-terminal fragments between both proteases raised the question whether RHBDL4 may contribute to {eta}-secretase activity and A{eta}-like fragments. Here, we identified two cleavage sites of RHBDL4 in APP by mass spectrometry, which, intriguingly, lie in close proximity to the cleavage sites of MT5-MMP. Indeed, we observed that RHBDL4 generates A{eta}-like fragments in vitro without contributions of -, {beta}-, or {gamma}-secretases. Such A{eta}-like fragments are likely generated in the ER since RHBDL4-derived APP-C-terminal fragments do not reach the cell surface. Inherited, familial APP mutations appear to not affect this processing pathway. In RHBDL4 knockout mice, we observed increased cerebral full length APP levels in comparison to WT brains in support of RHBDL4 being a physiologically relevant protease for APP. Furthermore, we found secreted A{eta} fragments in dissociated mixed cortical cultures from wild type mice, however significantly less A{eta} fragments in cultures from RHBDL4 knockout mice. Our data underscores that RHBDL4 contributes to {eta}-secretease-like processing of APP and that RHBDL4 is a physiologically relevant protease for APP.